ONCOLOGY INSTITUTE INC/THE (TOI)
US68236X1000 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 33.49M | 14.00M | 114.30M | 6.00M | 2.40M | |||
| Marketable Securities | 49.37M | 59.80M | N/A | N/A | N/A | |||
| Receivables | 42.91M | 40.40M | 21.20M | 17.30M | 14.70M | |||
| Inventories | 13.68M | 9.30M | 6.40M | 4.40M | 3.90M | |||
| Other Current Assets | 4.05M | 6.90M | 12.10M | 2.10M | 700.00K | |||
| Total Current Assets | 143.49M | 130.40M | 154.10M | 29.70M | 21.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 40.05M | 33.00M | 4.20M | 2.10M | 1.60M | |||
| Investments And Advances | 0.00 | 58.40M | N/A | 230.25M | N/A | |||
| Goodwill | 7.23M | 21.40M | 26.60M | 14.20M | 14.10M | |||
| Intangibles | 17.90M | 18.00M | 18.20M | 19.50M | 22.00M | |||
| Other Non-Current Assets | 561.00K | 500.00K | 300.00K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 65.75M | 131.30M | 49.30M | 36.00M | 37.70M | |||
| TOTAL ASSETS | 209.24M | 261.70M | 203.40M | 65.70M | 59.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 200.00K | 5.40M | 0.00 | |||
| Accrued Expenses | 16.76M | 16.90M | 10.70M | 4.30M | 1.50M | |||
| Accounts Payable | 14.43M | 9.40M | 15.60M | 12.60M | 8.90M | |||
| Other Current Liabilities | 3.60M | 3.50M | 3.40M | 6.30M | 3.20M | |||
| Total Current Liabilities | 34.79M | 29.70M | 29.80M | 28.60M | 13.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 86.83M | 80.60M | 0.00 | 6.60M | 0.00 | |||
| Deferred Taxes/Income | 32.00K | 100.00K | 400.00K | 1.60M | 3.00M | |||
| Other Non-Current Liabilities | 30.57M | 28.00M | 69.10M | 800.00K | 800.00K | |||
| Total Non-Current Liabilities | 117.43M | 108.80M | 69.50M | 9.00M | 3.70M | |||
| TOTAL LIABILITIES | 152.22M | 138.50M | 99.30M | 37.60M | 17.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -146.15M | -63.10M | -63.20M | -52.30M | -6.00M | |||
| Additional Paid In Capital | 204.19M | 186.30M | 167.40M | 80.40M | 100.00K | |||
| Common Shares | 8.00K | 0.00 | 0.00 | 0.00 | 48.10M | |||
| Treasury Stock | -1.02M | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 74.15M | 73.30M | 73.20M | 74.60M | 74.60M | |||
| Tangible Book Value per Share | 0.43 | 1.14 | 0.81 | -0.08 | -0.56 | |||
| Total Shareholders' Equity | 57.02M | 123.20M | 104.20M | 28.10M | 42.20M | |||
| TOTAL LIABILITIES AND EQUITY | 209.24M | 261.70M | 203.40M | 65.70M | 59.50M | |||
| Statistics | ||||||||
| Debt/Equity | 1.52 | 0.65 | N/A | 0.23 | N/A | |||
| Current Ratio | 4.12 | 4.39 | 5.17 | 1.04 | 1.60 | |||
| Return On Assets (ROA) | -32.44% | 0.04% | -5.36% | -21.77% | -6.72% | |||
| Return On Equity (ROE) | -119.03% | 0.08% | -10.46% | -50.89% | -9.48% | |||
All data in USD